Among locoregional treatments for hepatocellular carcinoma (HCC), radiofrequency
ablation (RFA) has been accepted as the most popular alternative to curative transplantation …

Loco-regional treatments for hepatocellular carcinoma (HCC) are important alternatives to
curative transplantation or resection. Among them, radiofrequency ablation (RFA) is …

Radiofrequency ablation (RFA) has gained a wide acceptance as a first-line therapeutic
option for small hepatocellular carcinoma (HCC). For very early-stage HCC, despite a higher …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related
mortality worldwide. Unfortunately, only 20% of HCC patients are amenable to curative …

Objective: To review the current status of radiofrequency ablation (RFA) in the management
of hepatocellular carcinoma (HCC). Summary Background Data: The development of local …

Ablation therapy is one of the best curative treatment options for malignant liver tumors, and
can be an alternative to resection. Radiofrequency ablation (RFA) of primary and secondary …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …

Hepatocellular carcinoma (HCC) is the third leading cause of death in the malignant
neoplastic diseases in the world. Surgical operation is sometimes not indicated because of …

Radiofrequency ablation (RFA) of liver cancers can be performed safely using
percutaneous, laparoscopic, or open surgical techniques, and much of the impetus for the …

Hepatocellular carcinoma (HCC) is a malignant disease that substantially affects public
health worldwide. It is especially prevalent in east Asia and sub-Saharan Africa, where the …